Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-12-23
|
pubmed:abstractText |
Surgically stressed rats maintained with total parenteral nutrition (TPN) exhibit jejunal atrophy, which can be attenuated by insulin-like growth factor-I (IGF-I) but not by growth hormone (GH) treatment. In order to understand the basis for the selective action of IGF-I, the levels of mRNAs encoding IGF-I, IGF-binding proteins (IGFBPs), IGF-I receptor, and GH receptor/binding protein (GHR/GHBP) were determined in rats given TPN and treated with GH, IGF-I, or GH + IGF-I. GH treatment significantly stimulated hepatic IGF-I mRNA. IGF-I treatment did not alter liver IGF-I mRNA, nor was there any evidence for interaction between GH and IGF-I. Jejunal mucosa IGF-I mRNA was extremely low and was not altered by TPN or by any of the hormonal treatments. The inability of GH to stimulate jejunal growth was not associated with a deficiency in GHR/GHBP mRNA. In jejunal mucosa, IGF-I and GH treatment independently and synergistically stimulated IGFBP-3 mRNA. IGF-I stimulated jejunal IGFBP-5 mRNA, but GH had no effect on IGFBP-5 mRNA. The levels of IGF-I receptor and IGFBP-1, 2, 4, and 6 mRNAs were extremely low and/or were not altered by any of the treatments. These results suggest that the ability of exogenous IGF-I, but not GH, to induce IGFBP-5 mRNA in jejunal mucosa may lead to the selective growth-promoting effect of IGF-I. Jejunal mucosa IGFBP-3 mRNA levels were not correlated with altered growth. We postulate that IGFBP-5 positively modulates the anabolic effects induced by exogenous IGF-I in the jejunum.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatotropin,
http://linkedlifedata.com/resource/pubmed/chemical/somatotropin-binding protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0037-9727
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
216
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
438-45
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9402151-Animals,
pubmed-meshheading:9402151-Body Weight,
pubmed-meshheading:9402151-Carrier Proteins,
pubmed-meshheading:9402151-Cell Division,
pubmed-meshheading:9402151-Human Growth Hormone,
pubmed-meshheading:9402151-Infusions, Parenteral,
pubmed-meshheading:9402151-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:9402151-Insulin-Like Growth Factor Binding Protein 5,
pubmed-meshheading:9402151-Insulin-Like Growth Factor I,
pubmed-meshheading:9402151-Intestinal Mucosa,
pubmed-meshheading:9402151-Jejunum,
pubmed-meshheading:9402151-Liver,
pubmed-meshheading:9402151-Male,
pubmed-meshheading:9402151-RNA, Messenger,
pubmed-meshheading:9402151-Rats,
pubmed-meshheading:9402151-Rats, Sprague-Dawley,
pubmed-meshheading:9402151-Receptors, Somatotropin
|
pubmed:year |
1997
|
pubmed:articleTitle |
Stimulation of intestinal growth is associated with increased insulin-like growth factor-binding protein 5 mRNA in the jejunal mucosa of insulin-like growth factor-I-treated parenterally fed rats.
|
pubmed:affiliation |
Department of Biochemistry, University of Texas Health Science Center at San Antonio, 78284-7760, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|